ATE199321T1 - Anti idiotypische antikörper gegen gonococcen und diese verwendende verfahren und zusammensetzungen. - Google Patents

Anti idiotypische antikörper gegen gonococcen und diese verwendende verfahren und zusammensetzungen.

Info

Publication number
ATE199321T1
ATE199321T1 AT94912962T AT94912962T ATE199321T1 AT E199321 T1 ATE199321 T1 AT E199321T1 AT 94912962 T AT94912962 T AT 94912962T AT 94912962 T AT94912962 T AT 94912962T AT E199321 T1 ATE199321 T1 AT E199321T1
Authority
AT
Austria
Prior art keywords
idiotypic antibodies
compositions
methods
gonococces
same
Prior art date
Application number
AT94912962T
Other languages
English (en)
Inventor
Peter A Rice
Sunita Gulati
Daniel P Mcquillen
Original Assignee
Peter A Rice
Sunita Gulati
Daniel P Mcquillen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Peter A Rice, Sunita Gulati, Daniel P Mcquillen filed Critical Peter A Rice
Application granted granted Critical
Publication of ATE199321T1 publication Critical patent/ATE199321T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4208—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig
    • C07K16/4233—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-bacterial Ig
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/77—Internalization into the cell

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT94912962T 1993-04-06 1994-04-06 Anti idiotypische antikörper gegen gonococcen und diese verwendende verfahren und zusammensetzungen. ATE199321T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/043,663 US5476784A (en) 1993-04-06 1993-04-06 Gonococcal anti-idiotypic antibodies and methods and compositions using them
PCT/US1994/003794 WO1994022479A1 (en) 1993-04-06 1994-04-06 Gonococcal anti-idiotypic antibodies and methods and compositions using them

Publications (1)

Publication Number Publication Date
ATE199321T1 true ATE199321T1 (de) 2001-03-15

Family

ID=21928258

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94912962T ATE199321T1 (de) 1993-04-06 1994-04-06 Anti idiotypische antikörper gegen gonococcen und diese verwendende verfahren und zusammensetzungen.

Country Status (12)

Country Link
US (4) US5476784A (de)
EP (1) EP0695192B1 (de)
CN (1) CN1118299C (de)
AT (1) ATE199321T1 (de)
AU (1) AU698908B2 (de)
CA (1) CA2164123A1 (de)
DE (1) DE69426767D1 (de)
HK (1) HK1016017A1 (de)
NZ (1) NZ265000A (de)
OA (1) OA10187A (de)
SG (1) SG48816A1 (de)
WO (1) WO1994022479A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5476784A (en) * 1993-04-06 1995-12-19 Rice; Peter A. Gonococcal anti-idiotypic antibodies and methods and compositions using them
US5674493A (en) * 1993-08-31 1997-10-07 Thomas Jefferson University Compositions and methods for targeting cells with A2R and A2R monoclonal antibodies
US5612030A (en) * 1995-01-17 1997-03-18 University Of Kentucky Research Foundation Anti-idiotype monoclonal antibody 1A7 and use for the treatment of melanoma and small cell carcinoma
US5935821A (en) 1995-01-17 1999-08-10 Board Of Trustees Of The University Of Kentucky Polynucleotides related to monoclonal antibody 1A7 and use for the treatment of melanoma and small cell carcinoma
US5977316A (en) * 1995-01-17 1999-11-02 The Board Of Trustees Of The University Of Kentucky Monoclonal antibody 1A7 and related polypeptides
US6074641A (en) * 1995-06-07 2000-06-13 Rice; Peter A. Gonococcal anti-idiotypic antibodies and methods and compositions using them
AU763029B2 (en) * 1997-11-14 2003-07-10 Euro-Celtique S.A. Immunoglobulin molecules having a synthetic variable region and modified specificity
US6645503B1 (en) * 1998-03-10 2003-11-11 Wyeth Holdings Corporation Antigenic conjugates of conserved lipopolysaccharides of gram negative bacteria
GB9808327D0 (en) 1998-04-20 1998-06-17 Chiron Spa Antidiotypic compounds
CN101638433B (zh) * 1999-10-29 2014-10-29 彼得·A·赖斯 保守淋球菌表位的拟肽及应用它们的方法和组合物
US7189405B1 (en) * 1999-10-29 2007-03-13 Rice Peter A Peptide mimics of conserved gonococcal epitopes and methods and compositions using them
WO2003002908A1 (en) * 2000-06-26 2003-01-09 Reveo, Inc. Backlight for a liquid crystal display having high light-recycling efficiency
FR2858326A1 (fr) * 2003-08-01 2005-02-04 Abtech Procede de preparation d'anticorps mimetiques d'une substance et les anticorps ainsi obtenus
US20060073534A1 (en) * 2004-10-05 2006-04-06 The University Of Georgia Research Foundation, Inc Method for cleaving and deglycosylating antibodies to promote ligand binding
GB0819633D0 (en) * 2008-10-25 2008-12-03 Isis Innovation Composition

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4699880A (en) * 1984-09-25 1987-10-13 Immunomedics, Inc. Method of producing monoclonal anti-idiotype antibody
US5476784A (en) * 1993-04-06 1995-12-19 Rice; Peter A. Gonococcal anti-idiotypic antibodies and methods and compositions using them

Also Published As

Publication number Publication date
DE69426767D1 (de) 2001-04-05
CN1124456A (zh) 1996-06-12
CN1118299C (zh) 2003-08-20
US5476784A (en) 1995-12-19
US5888509A (en) 1999-03-30
OA10187A (en) 1996-12-18
EP0695192A1 (de) 1996-02-07
EP0695192B1 (de) 2001-02-28
AU6530494A (en) 1994-10-24
US6099839A (en) 2000-08-08
CA2164123A1 (en) 1994-10-13
AU698908B2 (en) 1998-11-12
NZ265000A (en) 1997-12-19
WO1994022479A1 (en) 1994-10-13
US5939067A (en) 1999-08-17
HK1016017A1 (en) 1999-10-22
SG48816A1 (en) 1998-05-18

Similar Documents

Publication Publication Date Title
BR9502707A (pt) Composto composição farmacêutica e método para o tratamento de uma afecção
NO961326D0 (no) Inhibitorer av
ATE199321T1 (de) Anti idiotypische antikörper gegen gonococcen und diese verwendende verfahren und zusammensetzungen.
MXPA05003621A (es) Metodos de tratamiento de la enfermedad de alzheimer usando anticuerpos dirigidos contra el peptido beta amiloide y composiciones de los mismos.
ATE364699T1 (de) Humanisierte antikörper gegen humanes gp39, zusammensetzungen die diese enthalten und deren therapeutische verwendungen
IL148079A0 (en) Human ctla-4 antibodies and compositions containing the same
LU91271I2 (fr) Natalizumab et ses dérivés pharmaceutiquement acceptables (TYSABRI)
DK0705100T3 (da) Terapeutiske substituerede guanidiner
ATE240395T1 (de) Antikörper gegen e-selektin
BR0008688A (pt) Antagonistas de il-18 recombinantes utilizáveis no tratamento de distúrbios mediados por il-18
YU46097A (sh) Nova klasa estara i njihove farmaceutske smeše
NL300224I2 (nl) 3-Benzazepinzonen gesubstitueerd met een benzocyclobutyl- of indanylalkylaminoalkylgroep, bruikbaar voor de behandeling van cardiovasculaire aandoeningen.
MX9705235A (es) Inhibidores de calpaina y/o catepsina b de oxazolidina substituida.
ES2113891T3 (es) Anticuerpos monoclonales de raton.
FI972703A0 (fi) Rekombinantti IL-5-antagonisteja, jotka ovat käyttökelpoisia hoidettaessa IL-5:een liittyviä sairauksia
TR199700999T1 (xx) Askomisinler.
DE69125485T2 (de) Verfahren und zwischenprodukte synthetischer antikörperderivate
DK1082131T3 (da) Immunoregulator
LV11593A (lv) Dimetikona pielietojums aizcietejumu arstesana
ATE271384T1 (de) Arylnitron therapeutische mittel zur behandlung von entzündlichen darmerkrankungen
TR199700791T1 (xx) Kendiliğinden bağışıklığı olan hastalıkların ve allograft rejeksiyonun tedavisi için LCK SH2 spesifik bileşimlerinin kullanılması.
RU93035807A (ru) Способ лечения юношеского эпифизиолиса

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties